Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 2XQG | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by racemic VR | |
| 2XQI | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by racemic CVX | |
| 2XQJ | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R) | |
| 2XQK | P06276 | X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S) | |
| 2Y1K | P06276 | STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT | |
| 3DJY | P06276 | Nonaged Form of Human Butyrylcholinesterase Inhibited by Tabun | |
| 3DKK | P06276 | Aged Form of Human Butyrylcholinesterase Inhibited by Tabun | |
| 4AQD | P06276 | Crystal structure of fully glycosylated human butyrylcholinesterase | |
| 4AXB | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with 2-PAM | |
| 4B0O | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate | |
| 4B0P | P06276 | Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium | |
| 4BBZ | P06276 | Structure of human butyrylcholinesterase inhibited by CBDP (2-min soak): Cresyl-phosphoserine adduct | |
| 4BDS | P06276 | Human butyrylcholinesterase in complex with tacrine | |
| 4TPK | P06276 | Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-methoxyethyl)-2-naphthamide | |
| 4XII | P06276 | X-ray structure of human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-8-hydroxy-N-(2-methoxyethyl)-5-nitroquinoline-7-carboxamide | Butyrylcholinesterase (E.C.3.1.1.8) |
| 5DYT | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-methylnaphthalene-2-sulfonamide | |
| 5DYW | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-(2-methoxyethyl)naphthalene-2-sulfonamide | |
| 5DYY | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)naphthalene-2-sulfonamide | |
| 5K5E | P06276 | Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening | |
| 5LKR | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | Cholinesterase (E.C.3.1.1.8) |
| 5NN0 | P06276 | Crystal structure of huBChE with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-(dimethylamino)ethyl)-2-naphthamide. | Cholinesterase (E.C.3.1.1.8) |
| 6F7Q | P06276 | Human Butyrylcholinesterase complexed with N-Propargyliperidines | |
| 6I0B | P06276 | Human butyrylcholinesterase in complex with the S enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. | |
| 7QBQ | P06276 | Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | |
| 7QBR | P06276 | Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | |
| 7QHD | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
| 7QHE | P06276 | Human Butyrylcholinesterase in complex with (S)-1-(4-((naphthalen-1-yl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide | |
| 7Q1M | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1N | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1O | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1P | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7BO3 | P06276 | Human Butyrylcholinesterase in complex with N-(2-(1H-Indol-3-yl)ethyl)-2-cycloheptyl-N-methylethan-1-amine | |
| 7BO4 | P06276 | Human Butyrylcholinesterase in complex with 3-(2-(butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-6-ol | |
| 7AWI | P06276 | Crystal structure of human butyrylcholinesterase in complex with tert-butyl 3-(((2-((1-benzyl-1H-indol-4-yl)oxy)ethyl)amino)methyl]piperidine-1-carboxylate | |
| 7ZPB | P06276 | Structure of hemiacetylated human butyrylcholinesterase upon reaction with 8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinoline-2-carbaldehyde | |
| 8AI7 | P06276 | Structure of carbamoylated human butyrylcholinesterase upon reaction with 3-(((2-cycloheptylethyl)(methyl)amino)methyl)-1H-indol-7-yl N,N-dimethylcarbamate | |
| 7U6E | P06213-2 | Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 | |
| 7MD5 | P06213 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
| 6VEP | P06213 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
| 6VEQ | P06213 | Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
| 6CE9 | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
| 6CEB | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
| 6HN4 | P06213 | Leucine-zippered human insulin receptor ectodomain with single bound insulin - "lower" membrane-proximal part | |
| 6HN5 | P06213 | Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-distal part | |
| 7KD6 | P06213 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
| 2HR7 | P06213 | Insulin receptor (domains 1-3) | |
| 3W11 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha-CT peptide(704-719) and FAB 83-7 | |
| 3W12 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
| 3W13 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 | |
| 4OGA | P06213 | Insulin in complex with Site 1 of the human insulin receptor |
